On 15 October 2026, the Distinguished Lecturer Series welcomed Prof. David A. Hildeman from the Department of Pediatrics at Cincinnati Children’s Hospital Medical Center, USA.

His lecture, “Deconstructing human allograft rejection – novel insights into allospecificity,” addressed immune responses involved in the rejection of transplanted tissue. Hosted by Prof. Jörg Köhl, the event took place in Lübeck with additional participation via Webex.

For RTG 3095 doctoral researchers, the lecture…

RTG 3095 is expanding: the German Research Foundation (DFG) has approved funding for a tenth research project, led by Prof. Patrick Maschmeyer, starting in August 2026.

P10 will investigate how diet and metabolic changes influence the formation and function of memory B cells and antibody-producing plasma cells. A particular focus is how high-fat diets and obesity may alter cellular interactions and gene-regulatory programmes during allergic immune responses.

The project adds expertise in…

On 9 July 2026, Prof. Verena Raker from the University of Augsburg contributed to the Distinguished Lecturer Series with her talk “Contact Allergy Beyond the Rash: Innate Recognition and Commensal Immune Regulation.”

Hosted by Prof. Jennifer Hundt, the lecture took place in Lübeck and was accessible online via Webex. Its focus on innate recognition and commensal immune regulation offered perspectives relevant to understanding allergic inflammation at the skin barrier.

The event formed part…

On 11 June 2026, RTG 3095 welcomed Dr Laura van Dam for its first Distinguished Lecturer Series event within the qualification programme.

A Marie Skłodowska-Curie Postdoctoral Fellow in the Robinson Lab at Stanford University, Laura van Dam studies the molecular mechanisms underlying ANCA-associated vasculitis. Her research focuses on identifying ANCA-specific B and T cells and investigating potential microbial triggers and molecular mimicry. With training in both medicine and biomedical…